Live Bending Spoons Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Taysha Gene Therapies, Inc.

TSHA

Latest SEC Filings from Taysha Gene Therapies, Inc.

  1. 1
    1

    Taysha Gene Therapies Reports Zero Revenue and Increased Losses in Q2 2026

    via official filing (AI summary) 2 months ago 0 comments
  2. 2
    1

    Taysha Gene Therapies Reports $42.4 Million Net Loss in Q1 2026

    via official filing (AI summary) 6 months ago 0 comments
  3. 3
    1

    Taysha Gene Therapies Reports $109M Net Loss and Progress on TSHA-102 in 10-K Filing

    via official filing (AI summary) 7 months ago 0 comments
  4. 4
    1

    Taysha Gene Therapies Reports No Revenue and Increased Losses in Latest Quarter

    via official filing (AI summary) 12 months ago 0 comments
  5. 5
    1

    Taysha Gene Therapies Reports Q2 2025 Revenue Growth to $1.986 Million Amid Increased Losses

    via official filing (AI summary) about 1 year ago 0 comments
  6. 6
    1

    Taysha Gene Therapies Reports $21.5 Million Net Loss in Q1 2025

    via official filing (AI summary) over 1 year ago 0 comments
  7. 7
    1

    Taysha Gene Therapies Reports $1.8M Revenue, Net Loss of $25.5M in Q3 2024

    via official filing (AI summary) almost 2 years ago 0 comments